Clinical Trial Update: Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of INV-102 Ophthalmic Solution for moderate-to-severe dry eye disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• INV-102 Ophthalmic Solution (INV-102)

Snippet

Sponsor: Invirsa, Inc. | Conditions: Dry Eye Disease | Phase 2 | Status: COMPLETED